Allscripts (NASDAQ:MDRX) has signed a definitive agreement to sell its OneContent business to Hyland Software, Inc., a leading provider of content services solutions to the healthcare industry and beyond. The deal is expected to close in the second quarter once customary closing conditions are satisfied.

Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.

Abbott (NYSE: ABT) announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones(2) (both iPhone and Android). People with diabetes living in Europe and using the FreeStyle® Libre system(3) are now able to access glucose data directly from their smartphones, eliminating the need to carry the separate FreeStyle Libre reader(4) (a handheld device used to scan the FreeStyle Libre sensor to get a glucose result).

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists of bedside, transport, mobile and central station monitoring technology backed by a new approach to consulting, training, service and customer support, including a full range of product support and expert services.

East Lancashire Hospitals NHS Trust (ELHT) has chosen global health information technology leader Cerner as its Preferred Supplier of a new clinical information system that will help to improve the quality, safety and efficiency of patient care. The system, commonly known as 'Electronic Patient Record' (EPR), is the intelligent software which brings each patient's key clinical and administrative data together in one place.

One of the best-known users of telehealth in England has awarded a contract to Docobo to significantly expand its service over the next three years. NHS Liverpool Clinical Commissioning Group started scaling up telehealth in 2013, through its More Independent or Mi Programme, which was part-funded by the Innovate UK dallas initiative.

Throughout the MSD Innovation Factory, MSD launched 7 health-related challenges to award the three most outstanding solutions. Blendarsys, Symptoma and Grupo Pulso are the winners out of 100 proposals. The companies will receive up to $20,000 each to co-create and roll-out their solution with MSD support.